Effects of Race and Sex on Measured GFR: The Multi-Ethnic Study of Atherosclerosis

American Journal of Kidney Diseases

Volumn 68, Issue 5, 2016, Pages 743-751

  Inker, Lesley A ^a   Shafi, Tariq ^b   Okparavero, Aghogho ^a   Tighiouart, Hocine ^a,c   Eckfeldt, John H ^d   Katz, Ronit ^e   Johnson, W Craig ^f   Dermond, Norma ^f   Tariq, Zarqa ^b   Benayache, Imene ^b   Post, Wendy S ^b   Coresh, Josef ^b   Levey, Andrew S ^a   Shlipak, Michael G ^g  

^a TUFTS MEDICAL CENTER   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f UNIVERSITY OF WASHINGTON   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

albumin creatinine ratio (ACR); albuminuria; body size; chronic kidney disease (CKD); ethnicity; GFR decline trajectory; Glomerular filtration rate (GFR); health disparities; iohexol; measured GFR; race; racial differences; renal function; sex

Indexed keywords

ALBUMIN; CREATININE; IOHEXOL;

AGED; ALBUMIN BLOOD LEVEL; ALBUMINURIA; ARTICLE; ATHEROSCLEROSIS; BLACK PERSON; BODY SIZE; BODY SURFACE; CAUCASIAN; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA CLEARANCE; RACE DIFFERENCE; SEX DIFFERENCE; VERY ELDERLY; COMPARATIVE STUDY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ATHEROSCLEROSIS; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; PROSPECTIVE STUDIES; SEX FACTORS;

EID: 84994851709     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2016.06.021     Document Type: Article

References (37)

1. 1 Levey, A.S., Coresh, J., Chronic kidney disease. Lancet 379:9811 (2012), 165–180.
2. 2 Collins, A.J., Foley, R.N., Chavers, B., et al. US Renal Data System 2013 annual data report. Am J Kidney Dis 63:1 suppl 1 (2014), e1–e420.
3. 3 Powe, N.R., To have and have not: health and health care disparities in chronic kidney disease. Kidney Int 64:2 (2003), 763–772.
4. 4 Wesson, L., Physiology of the Human Kidney. 1969, Grune & Stratton, New York, NY.
5. 5 Levey, A.S., Stevens, L.A., Schmid, C.H., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150:9 (2009), 604–612.
6. 6 Levey, A.S., Kramer, H., Obesity, glomerular hyperfiltration, and the surface area correction. Am J Kidney Dis 56:2 (2010), 255–258.
7. 7 Kramer, H., Jacobs, D.R. Jr., Bild, D., et al. Urine albumin excretion and subclinical cardiovascular disease. The Multi-Ethnic Study of Atherosclerosis. Hypertension 46:1 (2005), 38–43.
8. 8 Bild, D.E., Bluemke, D.A., Burke, G.L., et al. Multi-Ethnic Study of Atherosclerosis: objectives and design. Am J Epidemiol 156:9 (2002), 871–881.
9. 9 Inker, L.A., Okparavero, A., Tighiouart, H., et al. Midlife blood pressure and late-life GFR and albuminuria: an elderly general population cohort. Am J Kidney Dis 66:2 (2015), 240–248.
10. 10 Omnipaque (iohexol) injection [package insert]. Princeton, NJ: Amersham Health Inc; 2004.
11. 11 Brochner-Mortensen, J., A simple method for the determination of glomerular filtration rate. Scand J Clin Lab Invest 30:3 (1972), 271–274.
12. 12 Du Bois, D., Du Bois, E.F., A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5:5 (1989), 303–311 discussion 312-313.
13. 13 Abraham, A.G., Munoz, A., Furth, S.L., Warady, B., Schwartz, G.J., Extracellular volume and glomerular filtration rate in children with chronic kidney disease. Clin J Am Soc Nephrol 6:4 (2011), 741–747.
14. 14 SAS Institute Inc. SAS/STAT® 9.3 User's Guide. 2011, SAS Institute Inc, Cary, NC.
15. 15 R Development Core Team. R: A Language and Environment for Statistical Computing. 2014, R Foundation for Statistical Computing, Vienna, Austria.
16. 16 Stevens, L.A., Levey, A.S., Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20:11 (2009), 2305–2313.
17. 17 Levey, A.S., Inker, L.A., Coresh, J., GFR estimation: from physiology to public health. Am J Kidney Dis 63:5 (2014), 820–834.
18. 18 Kotchen, T.A., Piering, A.W., Cowley, A.W., et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension 35:3 (2000), 822–826.
19. 19 Parmer, R.J., Stone, R.A., Cervenka, J.H., Renal hemodynamics in essential hypertension. Racial differences in response to changes in dietary sodium. Hypertension 24:6 (1994), 752–757.
20. 20 El-Gharbawy, A.H., Kotchen, J.M., Grim, C.E., et al. Predictors of target organ damage in hypertensive blacks and whites. Hypertension 38:4 (2001), 761–766.
21. 21 Newsome, B.B., McClellan, W.M., Coffey, C.S., Allison, J.J., Kiefe, C.I., Warnock, D.G., Survival advantage of black patients with kidney disease after acute myocardial infarction. Clin J Am Soc Nephrol 1:5 (2006), 993–999.
22. 22 McClellan, W., Warnock, D.G., McClure, L., et al. Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort Study. J Am Soc Nephrol 17:6 (2006), 1710–1715.
23. 23 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:2 suppl 1 (2002), S1–S266.
24. 24 Derose, S.F., Rutkowski, M.P., Crooks, P.W., et al. Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health system. Am J Kidney Dis 62:2 (2013), 236–244.
25. 25 McClellan, W.M., Warnock, D.G., Judd, S., et al. Albuminuria and racial disparities in the risk for ESRD. J Am Soc Nephrol 22:9 (2011), 1721–1728.
26. 26 Peralta, C.A., Vittinghoff, E., Bansal, N., et al. Trajectories of kidney function decline in young black and white adults with preserved GFR: results from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Am J Kidney Dis 62:2 (2013), 261–266.
27. 27 Peralta, C.A., Katz, R., DeBoer, I., et al. Racial and ethnic differences in kidney function decline among persons without chronic kidney disease. J Am Soc Nephrol 22:7 (2011), 1327–1334.
28. 28 Eriksen, B.O., Mathisen, U.D., Melsom, T., et al. Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78:12 (2010), 1305–1311.
29. 29 Poggio, E.D., Rule, A.D., Tanchanco, R., et al. Demographic and clinical characteristics associated with glomerular filtration rates in living kidney donors. Kidney Int 75:10 (2009), 1079–1087.
30. 30 Jafar, T.H., Islam, M., Jessani, S., et al. Level and determinants of kidney function in a South Asian population in Pakistan. Am J Kidney Dis 58:5 (2011), 764–772.
31. 31 Schmieder, R.E., Beil, A.H., Weihprecht, H., Messerli, F.H., How should renal hemodynamic data be indexed in obesity?. J Am Soc Nephrol 5:9 (1995), 1709–1713.
32. 32 Anastasio, P., Spitali, L., Frangiosa, A., et al. Glomerular filtration rate in severely overweight normotensive humans. Am J Kidney Dis 35:6 (2000), 1144–1148.
33. 33 Inker, L.A., Tighiouart, H., Aspelund, T., et al. Lifetime risk of stage 3-5 CKD in a community-based sample in Iceland. Clin J Am Soc Nephrol 10:9 (2015), 1575–1584.
34. 34 Grams, M.E., Chow, E.K., Segev, D.L., Coresh, J., Lifetime incidence of CKD stages 3-5 in the United States. Am J Kidney Dis 62:2 (2013), 245–252.
35. 35 Saran, R., Li, Y., Robinson, B., et al. US Renal Data System 2015 Annual Data Report: epidemiology of kidney disease in the United States. Am J Kidney Dis, 67(3 suppl 1), 2016, S1S434.
36. 36 Nitsch, D., Grams, M., Sang, Y., et al. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ, 346, 2013, f324.
37. 37 Soveri, I., Berg, U.B., Bjork, J., et al. Measuring GFR: a systematic review. Am J Kidney Dis 64:3 (2014), 411–424.